In Cancer Trials, Minorities Face Extra Hurdles – New York Times
New York Times |
In Cancer Trials, Minorities Face Extra Hurdles
New York Times K.T. Jones has an aggressive type of Hodgkin's lymphoma. Getting immunotherapy in a clinical trial has kept him alive far past expectations. But few black patients participate in clinical trials. Credit Al Drago/The New York Times … |
